Edaravone

	Edaravone
Trade Name
Orphan Indication	Amyotrophic lateral sclerosis
USA Market Approval	USA
USA Designation Date	2015-05-12 00:00:00
Sponsor	Mitsubishi Tanabe Pharma Corporation;17-10, Nihonbashi-Koamicho, Chuo-ku, Tokyo 103-8405;